— Know what they know.
Not Investment Advice
Also trades as: TLX.AX (ASX) · $vol 22M · TLX (NASDAQ) · $vol 2M

TLPPF OTC

Telix Pharmaceuticals Limited
1W: -8.1% 1M: -3.2% 3M: -12.8% YTD: +40.9% 1Y: +15.3% 3Y: +45.9% 5Y: +104.2%
$10.72
-0.55 (-4.88%)
 
Weekly Expected Move ±14.9%
$8 $9 $11 $12 $14
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 53 · $3.6B mcap · 273M float · 0.0012% daily turnover · Short 64% of daily vol

📊 Key Metrics

TTM
$2B
Revenue
+201.7% YoY
$82M
Net Income
+602.3% YoY
$-83M
Free Cash Flow
-436.6% YoY
51.6%
Gross Margin
-2.9%
Op. Margin
8.0%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE14.8%
ROA6.0%
ROIC5.8%

Valuation

P/E109.7
P/B7.3
EV/EBITDA0.0

Leverage

Debt/Equity1.19
Current Ratio2.01
Interest Cov.1.7x

Quality Scores

Piotroski F5/9
Altman Z—
Beneish M0.06

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms